Alaunos Therapeutics | ZIOP - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Alaunos Therapeutics USD 447K 138K 2026-03
Amgen USD 1.58B 354M 2026-03
AstraZeneca USD 5.06B 455M 2026-03
Baxter International USD 728M 33M 2026-03
Biogen USD 554.3M 128.2M 2026-03
Bioline Rx USD 858K 257K 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Celltrion KRW 12.71B 237.27B 2025-12
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Curis USD 1.34M 3.45M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Gilead Sciences USD 1.45B 326M 2026-03
GlaxoSmithKline GBP 2.12B 558M 2026-03
Incyte USD 328.1M 62.31M 2026-03
Intrexon USD 10.31M 41K 2024-06
Ionis Pharmaceuticals USD 151M 21M 2026-03
J&J USD 6.03B 719M 2026-03
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Merck USD 2.67B 180M 2026-03
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Novartis USD 3.14B 296M 2026-03
Organigram Holdings CAD 22.01M 14.28M 2026-03
Ovoca Bio EUR 632K 2.33M 2025-06
Pfizer USD 2.92B 1.16B 2026-03
Pharma Mar EUR 15.31M 2M 2026-03
PTC Therapeutics USD 73.89M 13.31M 2026-03
Qiagen NV USD 153.88M 10.77M 2025-12
Regeneron Pharmaceuticals USD 647.7M 127.3M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
TG Therapeutics USD 73.14M 22.42M 2026-03
Tilray USD 24.85M 1.7M 2025-09
Verastem USD 24.44M 12.17M 2025-12
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03